Skip to main content
SpringerLink
Log in

Radiosynthesis and Evaluation of a C-11 Radiotracer for Transient Receptor Potential Canonical 5 in the Brain

  • Research Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Purpose

TRPC5 belongs to the mammalian superfamily of transient receptor potential (TRP) Ca2+-permeable cationic channels and it has been implicated in various CNS disorders. As part of our ongoing interest in the development of a PET radiotracer for imaging TRPC5, herein, we explored the radiosynthesis, and in vitro and in vivo evaluation of a new C-11 radiotracer [11C]HC070 in rodents and nonhuman primates.

Procedures

[11C]HC070 was radiolabeled utilizing the corresponding precursor and [11C]CH3I via N-methylation protocol. Ex vivo biodistribution study of [11C]HC070 was performed in Sprague–Dawley rats. In vitro autoradiography study was conducted for the rat brain sections to characterize the radiotracer distribution in the brain regionals. MicroPET brain imaging studies of [11C]HC070 were done for 129S1/SvImJ wild-type mice and 129S1/SvImJ TRPC5 knockout mice for 0–60-min dynamic data acquisition after intravenous administration of the radiotracer. Dynamic PET scans (0–120 min) for the brain of cynomolgus male macaques were performed after the radiotracer injection.

Results

[11C]HC070 was efficiently prepared with good radiochemical yield (45 ± 5%, n = 15), high chemical and radiochemical purity (> 99%), and high molar activity (320.6 ± 7.4 GBq/μmol, 8.6 ± 0.2 Ci/μmol) at the end of bombardment (EOB). Radiotracer [11C]HC070 has good solubility in the aqueous dose solution. The ex vivo biodistribution study showed that [11C]HC070 had a quick rat brain clearance. Autoradiography demonstrated that [11C]HC070 specifically binds to TRPC5-enriched regions in rat brain. MicroPET study showed the peak brain uptake (SUV value) was 0.63 in 129S1/SvImJ TRPC5 knockout mice compared to 1.13 in 129S1/SvImJ wild-type mice. PET study showed that [11C]HC070 has good brain uptake with maximum SUV of ~ 2.2 in the macaque brain, followed by rapid clearance.

Conclusions

Our data showed that [11C]HC070 is a TRPC5-specific radiotracer with high brain uptake and good brain washout pharmacokinetics in both rodents and nonhuman primates. The radiotracer is worth further investigating of its suitability to be a PET radiotracer for imaging TRPC5 in animals and human subjects in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Scheme 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Clapham DE, Runnels LW, Strübing C (2001) The TRP ion channel family. Nat Rev Neurosci 2:387–396

    Article  CAS  PubMed  Google Scholar 

  2. Riccio A, Li Y, Moon J et al (2009) Essential role for TRPC5 in amygdala function and fear-related behavior. Cell 137:761–772

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sharma S, Hopkins CR (2019) Review of transient receptor potential canonical (TRPC5) Channel modulators and diseases. J Med Chem 62:7589–7602

    Article  CAS  PubMed  Google Scholar 

  4. Wang H, Cheng X, Tian J et al (2020) TRPC channels: structure, function, regulation and recent advances in small molecular probes. Pharmacol Ther 209:107497

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Wright DJ, Simmons KJ, Johnson RM, Beech DJ, Muench SP, Bon RS (2020) Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site. Commun Biol 3:704

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. GFB-887 for TRPC5-Rac1-Mediated FSGS. Goldfinch Bio Company website (2022) https://www.goldfinchbio.com/pipeline/gfb-887/. Accessed 28 July 2022

  7. Yu Y, Liang Q, Liu H et al (2019) Development of a carbon-11 PET radiotracer for imaging TRPC5 in the brain. Org Biomol Chem 17:5586–5594

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Yu Y, Liang Q, Du L et al (2020) Synthesis and characterization of a specific iodine-125-labeled TRPC5 radioligand. ChemMedChem 15:1854–1860

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chenard B, Gallaschun R (2014) Substituted xanthines and methods of use thereof. Global patent, WO2014143799 A2

  10. Just S, Chenard BL, Ceci A et al (2018) Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice. PLoS One 13:e0191225

    Article  PubMed  PubMed Central  Google Scholar 

  11. Song K, Wei M, Guo W et al (2021) Structural basis for human TRPC5 channel inhibition by two distinct inhibitors. Elife 10:e63429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Waterhouse RN (2003) Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents. Mol Imaging Biol 5:376–389

    Article  PubMed  Google Scholar 

  13. Pike VW (2016) Considerations in the development of reversibly binding PET Radioligands for brain imaging. Curr Med Chem 23:1818–1869

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wilson AA, Jin L, Garcia A, DaSilva JN, Houle S (2001) An admonition when measuring the lipophilicity of radiotracers using counting techniques. Appl Radiat Isot 54:203–208

    Article  CAS  PubMed  Google Scholar 

  15. Strübing C, Krapivinsky G, Krapivinsky L, Clapham DE (2001) TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 29:645–655

    Article  PubMed  Google Scholar 

  16. Chung YH, Sun Ahn H, Kim D et al (2006) Immunohistochemical study on the distribution of TRPC channels in the rat hippocampus. Brain Res 1085:132–137

    Article  CAS  PubMed  Google Scholar 

  17. Riccio A, Medhurst AD, Mattei C et al (2002) mRNA distribution analysis of human TRPC family in CNS and peripheral tissues. Brain Res Mol Brain Res 109:95–104

    Article  CAS  PubMed  Google Scholar 

  18. Fowler MA, Sidiropoulou K, Ozkan ED, Phillips CW, Cooper DC (2007) Corticolimbic expression of TRPC4 and TRPC5 channels in the rodent brain. PLoS One 2:e573

    Article  PubMed  PubMed Central  Google Scholar 

  19. Zhang L, Villalobos A, Beck EM et al (2013) Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand. J Med Chem 56:4568–4579

    Article  CAS  PubMed  Google Scholar 

  20. Jeffries B, Wang Z, Graton J et al (2018) Reducing the lipophilicity of perfluoroalkyl groups by CF(2)-F/CF(2)-Me or CF(3)/CH(3) Exchange. J Med Chem 61:10602–10618

    Article  CAS  PubMed  Google Scholar 

  21. Shultz MD (2013) Setting expectations in molecular optimizations: strengths and limitations of commonly used composite parameters. Bioorg Med Chem Lett 23:5980–5991

    Article  CAS  PubMed  Google Scholar 

  22. Phelan KD, Shwe UT, Abramowitz J et al (2013) Canonical transient receptor channel 5 (TRPC5) and TRPC1/4 contribute to seizure and excitotoxicity by distinct cellular mechanisms. Mol Pharmacol 83:429–438

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Alawi KM, Russell FA, Aubdool AA et al (2017) Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation. Ann Rheum Dis 76:252–260

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors gratefully thank William H. Margenau and Patrick Zerkel of Washington University Cyclotron Facilities for C-11 radioisotope production, Nikki Fettig of the Mallinckrodt Institute of Radiology Preclinical Imaging Facility, and Emily Williams, Emily Flores, and John Hood of nonhuman primate imaging facility for their assistance with microPET imaging studies. We appreciate Ms. Lynne Jones for proofreading the manuscript.

Funding

This work was financially supported by the USA National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke, the National Institute on Aging [NS103988, NS075527 and NS103957].

Author information

Authors and Affiliations

  1. Department of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA

    Yanbo Yu, Hao Jiang, Qianwa Liang, Lin Qiu, Tianyu Huang, Joel S. Perlmutter & Zhude Tu

  2. Center for the Study of Itch and Sensory Disorders, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO, 63110, USA

    Hongzhen Hu

  3. Department of Psychiatry, McLean Hospital, Harvard Medical School, Boston, MA, 02115, USA

    Vadim Y. Bolshakov

  4. Department of Neurology, Washington University School of Medicine, St. Louis, MO, 63110, USA

    Joel S. Perlmutter

Authors
  1. Yanbo Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hao Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qianwa Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lin Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tianyu Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hongzhen Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Vadim Y. Bolshakov
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Joel S. Perlmutter
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhude Tu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zhude Tu.

Ethics declarations

Ethics Approval

All animal experiments were conducted in compliance with the Guide for the Care and Use of Laboratory Animals under Washington University’s Institutional Animal Care and Use Committee (IACUC)-approved protocols (20180188).

Conflict of Interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOC 239 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, Y., Jiang, H., Liang, Q. et al. Radiosynthesis and Evaluation of a C-11 Radiotracer for Transient Receptor Potential Canonical 5 in the Brain. Mol Imaging Biol 25, 334–342 (2023). https://doi.org/10.1007/s11307-022-01760-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-022-01760-y

Key words

Search

Navigation